AF
TMBR

Allworth Financial’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Allworth Financial’s Portfolio TMBR Stock Details TMBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4
Closed – – 2190
2021
Q3 		$0 Hold
4
– – ﹤0.01% 2012
2021
Q2 		$0 Hold
4
– – ﹤0.01% 1705
2021
Q1 		$0 Hold
4
– – ﹤0.01% 1655
2020
Q4 		$0 Buy
+4
New +$200 ﹤0.01% 1464

Other funds holding TMBR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Allworth Financial's TMBR Position: Q4 2021 in Review

Allworth Financial sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q4 2021, closing a stake of 4 shares.

Allworth Financial first reported a position in TMBR in Q4 2020 and held it in 4 quarters. The position peaked at $0 in Q3 2021. 17 funds tracked by Wall St. Rank hold TMBR as of Q4 2021.

  • Allworth Financial reported no remaining Timber Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • Allworth Financial sold 4 Timber Pharmaceuticals, Inc. shares in Q4 2021.
  • Allworth Financial first reported a position in Timber Pharmaceuticals, Inc. in Q4 2020 and held it in 4 quarters.
  • Allworth Financial's Timber Pharmaceuticals, Inc. position peaked at $0 in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q4 2021.

Based on Allworth Financial's 13F filing for Q4 2021, filed 21 Jan 2022.